Azafaros has licensed intellectual property from Leiden University and Amsterdam UMC's Academic Medical Centre to target lysosomal storage disorders.

UMC Utrecht spinout Gadeta has partnered cancer drug developer Kite to drive development of its T-cell therapy, allowing Kite to purchase equity from Gadeta's existing shareholders.

Old Mutual has supplied $68m to GV-backed online travel marketplace Secret Escapes, taking its funding to more than $251m to date.

Parkwalk has returned to back Oxford spinout Proxisense, which develops sensors for evaluating the status of industrial components.

The UCL and University of Houston spinout has raised more than $22m to date and is commercialising magnetic surgical guidance devices for breast cancer procedures.

Insuers Macif and Securex and several banks joined an LP list that helped BlackFin's first venture fund to a $117m first close a year ago.

Fuel cell technology developer Bramble is based on UCL and ICL intellectual property and previously worked with Parkwalk’s parent IP Group in January 2018.

The biologics production technology developer has secured $18.8m following a combined $6.8m from Takeda across 2015 and 2016.